EQUINOR WOS LIMITED

Financial Health Assessment: EQUINOR WOS LIMITED

1. Financial Health Score: A-

Explanation: The patient exhibits excellent overall health, characterized by a robust capital base, perfect regulatory compliance, and the financial backing of a multinational parent. The slight deduction (-) is due to minor administrative anomalies in the ownership records, which appear to be temporary symptoms of a recent corporate "transplant" (acquisition), rather than underlying financial distress.

2. Key Vital Signs

• Compliance Heartbeat (Excellent): The company’s regulatory pulse is strong and steady. Accounts are filed up to December 2024, with the next deadline not due until September 2026. The confirmation statement is also up to date. There are no symptoms of administrative distress or overdue filings.
• Capital Muscle (Excellent): With a share capital of £11.52 million, the company possesses a dense financial skeleton. This is not a frail startup; it is a well-capitalized entity with substantial equity padding to absorb operational shocks typical of the extractive energy sector.
• Corporate Genetics (Excellent): As a subsidiary of Equinor UK Limited (and previously Suncor Energy), this company carries the "DNA" of major global energy players. This provides it with a healthy cash flow lifeline and access to deep industry reserves.
• Director Turnover (Normal/Transitional): Recent resignations of directors (Camilla Salthe and Eystein Eikesdal) in early 2026, alongside the appointment of new directors, present as a normal post-acquisition immune response. The parent company is aligning the board with its own governance standards.
• PSC Register (Anomalous): The Persons with Significant Control (PSC) register currently shows two different entities (Equinor UK Limited and Suncor Energy UK Holdings Ltd) each owning more than 75% of shares and voting rights. This is a mathematical impossibility that signals an administrative lag in updating the official records following the acquisition.

3. Diagnosis

Diagnosis: Robust post-acquisition health with minor administrative inflammation.

The financial and structural data reveals a company in prime physical condition. Having been incorporated in 1970, this is a mature corporate entity that has successfully survived multiple "transplants"—most recently transitioning from Suncor Energy UK Limited to Equinor WOS Limited in July 2023.

The core business (SIC Code 6100: Extraction of crude petroleum) is capital-intensive and subject to volatile commodity markets, but the £11.5 million share capital and "Full" accounts filing status indicate a large, well-resourced organization capable of bearing these market stresses. The primary symptom of concern is the conflicting PSC register, which shows overlapping >75% ownership. This is not a symptom of financial illness, but rather an administrative scar from the recent takeover that requires a simple procedural clean-up.

4. Recommendations

To maintain optimal financial wellness and clear up the remaining administrative symptoms, the following specific actions are recommended:

1. Administer PSC Register Correction: File an immediate update with Companies House to resolve the overlapping PSC entries. The register should reflect only Equinor UK Limited as the current majority controller, removing the legacy Suncor Energy UK Holdings Ltd entry. This will clear the administrative inflammation and ensure corporate transparency.
2. Monitor Integration Vital Signs: Continue to monitor the transition of directorships and operational control. The recent board resignations are healthy, but ensuring continuity of local governance and compliance under the new Equinor regime is essential to prevent future regulatory infections.
3. Maintain Capital Reserves: Given the inherent volatility of the crude petroleum extraction sector, continue to leverage the strong £11.5m capital base to buffer against potential macroeconomic shocks, ensuring the company remains financially liquid during industry downturns.